January 10, 2025

Cambridge, MA and San Francisco, CA- January 10, 2025 – BioLabs, LabCentral and MBC BioLabs are excited to announce a five-year strategic partnership with AbbVie, a global biopharmaceutical company. AbbVie has long been a champion of the three organizations’ shared vision for advancing biotech entrepreneurship and continues to play a critical role in the networks they have cultivated over the past decade.

​​

This collaboration will focus on fostering early-stage innovation, enhancing the vibrant ecosystems nurtured by BioLabs, LabCentral and MBC BioLabs and support the over 500+ startups across the network of shared lab facilities in the United States, France, and Germany.